mcas and glutathione Can Liposomal Support Detoxification Energy in Long COVID and ME/CFS? Mast Cell Activation Syndrome (MCAS)

A narrative review of glutathione supplementation reported that 37.5 percent of participants receiving 1.2 g of glutathione twice weekly for six weeks experienced temporary lightening, yet benefits faded within six months, and 32 percent experienced adverse events such as liver dysfunction or anaphylaxis

Journal of clinical neurology (Seoul, Korea)

Impact of a purported nootropic supplementation on measures of mood, stress, and marksmanship performance in U.S

The sonic bang: its effects on man and animals

This investigational drug targets both GLP-1 and GIP receptors, resulting in up to 20% weight loss over 52 weeks

Taking Glutathione at Night: The Case for Repair While the day is about performance, the night is about restoration